Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

Clinical trial NCT01106131 · COMPLETED

Trial details

NCT number: NCT01106131
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-05-01
Primary completion: 2012-04-01
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.